Personalis Capital Stock from 2010 to 2024
| PSNL Stock | USD 3.93 0.20 5.36% |
Check Personalis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Personalis' main balance sheet or income statement drivers, such as , as well as many indicators such as . Personalis financial statements analysis is a perfect complement when working with Personalis Valuation or Volatility modules.
Personalis |
About Personalis Financial Statements
Personalis investors utilize fundamental indicators, such as Capital Stock, to predict how Personalis Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Personalis, Inc. operates as a cancer genomics company worldwide. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California. Personalis operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 325 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Personalis Correlation against competitors. For more information on how to buy Personalis Stock please use our How to buy in Personalis Stock guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Healthcare space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Personalis. If investors know Personalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Personalis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Personalis is measured differently than its book value, which is the value of Personalis that is recorded on the company's balance sheet. Investors also form their own opinion of Personalis' value that differs from its market value or its book value, called intrinsic value, which is Personalis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Personalis' market value can be influenced by many factors that don't directly affect Personalis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Personalis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Personalis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Personalis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.